ZBAO:NASDAQZhibao Technology Inc. Analysis
Data as of 2026-05-12 - not real-time
$0.77
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Zhibao Technology posted a ~41% revenue surge, signaling that its top‑line growth strategy is gaining traction despite a negative profit margin and a loss per share. The stock trades around $0.77 while a discounted cash‑flow model suggests a fair value near $55, implying a massive valuation gap. Technicals remain weak: the 20‑day SMA sits below both the 50‑day and 200‑day averages, confirming a bearish price trend, and the price is still below the recent resistance level of $1.19. However, the MACD has just crossed into bullish territory and the RSI hovers around the 50‑point neutral zone, hinting at a possible short‑term bounce. Volume is on an upward trajectory, which could support a breakout if buyer sentiment improves. At the same time, the stock exhibits extreme 30‑day volatility (>125%) and a modest beta, suggesting price swings are driven more by company‑specific factors than market moves.
Investors should weigh the stark valuation upside against the company's high debt load, negative operating cash flow, and regulatory exposure in China. The current support around $0.58 offers a floor, but the path to the DCF target requires a sustained turnaround in profitability and cash generation. A cautious stance is warranted in the near term, while the long‑run upside remains compelling if the firm can convert revenue growth into positive earnings and manage its balance sheet.
Investors should weigh the stark valuation upside against the company's high debt load, negative operating cash flow, and regulatory exposure in China. The current support around $0.58 offers a floor, but the path to the DCF target requires a sustained turnaround in profitability and cash generation. A cautious stance is warranted in the near term, while the long‑run upside remains compelling if the firm can convert revenue growth into positive earnings and manage its balance sheet.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- bearish technical trend with SMA hierarchy
- proximity to recent support level
- elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- robust revenue growth exceeding 40%
- DCF‑derived valuation gap
- increasing trading volume indicating accumulating interest
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- potential market share expansion in China's digital insurance space
- long‑run tailwinds for fintech and insurance brokerage
- significant undervaluation relative to intrinsic fair value
Key Metrics & Analysis
Financial Health
Revenue Growth40.70%
Profit Margin-19.52%
ROE-99.67%
ROA-11.02%
Debt/Equity111.55
P/B Ratio8.8
Op. Cash Flow$-107109984
Free Cash Flow$52.5M
Industry P/E16.5
Technical Analysis
TrendBearish
RSI52.1
Support$0.58
Resistance$1.19
MA 20$0.77
MA 50$0.82
MA 200$0.93
MACDBullish
VolumeIncreasing
Fear & Greed Index87.98
Valuation
Fair Value$55.66
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.05
Volatility125.15%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.